|
Volumn 297, Issue 5581, 2002, Pages 609-611
|
Activation of central melanocortin pathways by fenfluramine
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ELECTROPHYSIOLOGY;
NEUROLOGY;
ANTIOBESITY TREATMENT;
DRUG PRODUCTS;
FENFLURAMINE;
MELANOCORTIN;
DRUG PRESCRIBING;
WEIGHT;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CENTRAL NERVOUS SYSTEM;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG WITHDRAWAL;
ELECTROPHYSIOLOGY;
HEART DISEASE;
HUMAN;
MALE;
MOUSE;
NEUROANATOMY;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
ALPHA-MSH;
ANIMALS;
APPETITE DEPRESSANTS;
ARCUATE NUCLEUS;
FEEDING BEHAVIOR;
FENFLURAMINE;
MALE;
MELANOCYTE-STIMULATING HORMONES;
MICE;
MICE, OBESE;
MICE, TRANSGENIC;
NEURONS;
PARAVENTRICULAR HYPOTHALAMIC NUCLEUS;
PATCH-CLAMP TECHNIQUES;
PRO-OPIOMELANOCORTIN;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTOR, MELANOCORTIN, TYPE 3;
RECEPTOR, MELANOCORTIN, TYPE 4;
RECEPTOR, SEROTONIN, 5-HT2C;
RECEPTORS, CORTICOTROPIN;
RECEPTORS, SEROTONIN;
SEROTONIN;
SEROTONIN AGENTS;
ANIMALIA;
RODENTIA;
|
EID: 0037178730
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1072327 Document Type: Article |
Times cited : (426)
|
References (29)
|